Navigation Links
MyClyns(TM) Now Available in Single Units
Date:5/29/2008

UNION, Ky., May 29 /PRNewswire/ -- Union Springs Pharmaceuticals, LLC, announced today it will now offer MyClyns in individually wrapped single units. These new packages provide enhanced tamper-proof protection for each MyClyns unit and also afford customers greater purchasing flexibility. Each sealed package will contain one MyClyns unit and a label card with directions for use and other important product information.

Furthermore, cases of MyClyns will now contain twenty-four single units rather than the eight three-packs found in previous cases. However, three- packs will be available for a short time while inventory lasts.

"Based on the feedback we have received from our customers, we are now pleased to offer individually packaged units for our customers," said Joel Ivers, President of Union Springs Pharmaceuticals. He added, "Customers wanted an easy way to determine whether a unit had been opened and they wanted the convenience to purchase one unit at a time. We satisfied both of these requests with one packaging solution."

MyClyns contains a fast-acting solution with germ-killing action that is safe to use on all mucous membranes including the eyes, ears, nose, mouth, and on open wounds. MyClyns' convenient pen-like design allows first responders to protect themselves immediately after exposure to potentially harmful pathogens when other alternatives are not available. Significantly, MyClyns is the only product on the market that can be safely used on the face. MyClyns is intended for immediate use by emergency medical, police, fire, corrections, military, healthcare providers, homeland security, and others exposed to bodily fluids.

About MyClyns(TM)

MyClyns(TM) (a pen-like device) is the only convenient, non-alcohol, first response spray providing personal protection immediately after a potentially pathogenic exposure. MyClyns contains a fast-acting solution with germ- killing action that is safe to use on all mucous membranes, including the eyes, nose, ears, mouth and on open wounds. Independent laboratory tests show that the solution in MyClyns demonstrated a 99.99% reduction in HIV-1, Hepatitis C, MRSA, C-diff and many other pathogens. MyClyns allows personnel to protect themselves after a pathogenic exposure when complete post-exposure protocols are rarely available. Visit the MyClyns website at http://www.myclyns.com for more information.

About Union Springs Pharmaceuticals, LLC

Union Springs Pharmaceuticals, LLC (USP) specializes in providing innovative over-the-counter (OTC) products for the consumer and healthcare markets. USP licenses, acquires, develops, and commercializes innovative products and technologies that satisfy the unmet needs of healthcare professionals and consumers. Union Springs Pharmaceuticals can be found on the Internet at http://www.uspharma.com


'/>"/>
SOURCE Union Springs Pharmaceuticals, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. First Responders Acquire Revolutionary MyClyns(TM) Protective Spray
2. CYNACON / OCuSOFT(R) Announces OCuSOFT(R) Lid Scrub(TM) PLUS Now Available in CVS Pharmacies
3. AMITIZA 8 mcg now available to treat irritable bowel syndrome
4. New Treatment Guide for Eating Disorders Available to Healthcare Professionals
5. Real Time, Face-to-Face Doctor Visits Now Available Online
6. SILS Surgical Technique Now Available at MUMC
7. AMDL Teleconference Available on amdl.com at 5:00 p.m. EDT Today
8. Healthy Farms, Healthy Schools Grant Applications Available
9. Wyeths Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies
10. Traditional Medicare Benefit Information Soon to be Available Online to Doctors and Hospitals through Blue Cross Blue Shield of Michigan Web Portal
11. Dr. Said Hakki, President of Iraqi Red Crescent Organization, in the United States and Available for Interviews May 12-16
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... CA (PRWEB) , ... February 27, 2017 , ... ... muscle mass and overall body strength, which often leads to a host of ... Journal of the American Geriatrics Society discovered that good overall muscle ...
(Date:2/27/2017)... ... 27, 2017 , ... Much attention has been paid to the problem of ... opioid painkillers has fallen short. From 1999 until 2010, fatal overdoses from prescription pain ... overdoses in male populations.(1) , The proportion of women using illicit drugs is also ...
(Date:2/27/2017)... ... February 27, 2017 , ... ... on laser diffraction analysis as a tool to characterize particle size distributions in ... to obtain improved results and novel scientific findings. It describes methods of optimized ...
(Date:2/27/2017)... ... 27, 2017 , ... Sunshine Coast Health Centre (SCHC), one ... at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the addition of a registered ... Centre's commitment to innovation in drug rehab and alcohol treatment strategies beyond a ...
(Date:2/26/2017)... ... ... The February 13, 2017, assassination of Kim Jong-nam, the half brother of ... deadly use of chemical weapons. Many questions exist about the effect that nerve agents ... lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan Neurosurgical Institute, and one of the ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... -- International Biophysics Corporation, a global medical device manufacturer based in ... revenue growth in 2016 when compared to the previous year ... was fueled by its AffloVest® sales in the ... its global sales of surgical product lines. Said ... our 25 th year in delivering high-quality, innovative medical ...
(Date:2/27/2017)... Calif. , Feb. 27, 2017   Vitasome ... line of nutritional supplements using its groundbreaking new liposome ... 90 percent of potency through digestion per Physician,s ... supplements solve the problem of nutritional waste and are ... degradation during digestive processes Improve bioavailability ...
(Date:2/27/2017)... Feb. 27, 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... development company focused on tissue protection, repair and ... GtreeBNT Co., Ltd., received a positive response from ... trial design for RGN-137 to treat epidermolysis bullosa ... that incorporates Thymosin beta 4 ("Tß4") as the ...
Breaking Medicine Technology: